Influence
March 21, 2022

Revolutionizing research through pragmatic trials

Regenstrief Institute Research Scientist Kathleen Unroe, M.D., MHA, M.S., is at the forefront of the next generation of research methodology: pragmatic trials. Pragmatic trials are designed to evaluate the effectiveness of interventions in real-life practice, speeding up the time from discovery to implementation.  

Dr. Unroe, along with Regenstrief faculty member Susan Hickman, PhD, is leading one of few pragmatic trials funded by the National Institute on Aging. The APPROACHES (Aligning Patient Preferences – a Role Offering Alzheimer’s patients, Caregivers, and Healthcare providers Education and Support) trial is being conducted in 150 nursing homes, testing an intervention to support advance care planning.  

She is also part of the IMPACT Collaboratory, a research incubator to develop pragmatic trials and train researchers to design and execute them.  

In 2021, Dr. Unroe spoke at a conference about pragmatic trials in long-term care facilities. The event identified priorities and best practices for trials taking place in these real-world settings. 

Dr. Unroe says she is excited about the potential of pragmatic trials for creating solutions as well as creating partnerships between researchers and healthcare systems.  

In addition to being a research scientist in the IU Center for Aging Research at Regenstrief Institute, Dr. Unroe is an associate professor at the IU School of Medicine and a practicing geriatrician. 

  • Kathleen Unroe

Related News

Susan Hickman and Kathleen Unroe lead expansion of advance care planning program

Leadership stability, peer support essential when implementing care programs in nursing homes

Despite a pressing need to improve outcomes and address inequities in nursing homes, there is limited evidence about the

Reimagining real-world health data as essential public infrastructure

Reimagining real-world health data as essential public infrastructure

Researchers propose standards and community oversight to improve interoperability, accountability and public trust The U.S. healthcare system runs on

Arthur H. Owora, PhD

Real-world effectiveness of asthma biologics by age of initiation and early-childhood risk factors

Published in Annals of the American Thoracic Society. Here is a link to the article.  Regenstrief Institute author: Arthur H. Owora, PhD,

LOINC® advances global health interoperability with semiannual concept release

LOINC® version 2.82 introduces new terminology and technical enhancements to support global data exchange Regenstrief Institute launched the LOINC®